Natera Inc (NTRA):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Natera Inc (NTRA) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C7862
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:58
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Natera Inc (Natera), formerly Gene Security Network Inc is a genetic testing and diagnostics company that develops and commercializes non-invasive methods for DNA analysis. The company offers products such as panorama prenatal testing, pre-implantation genetic testing, miscarriage testing, genetic carrier screening and paternity testing. Its pre-implantation genetic testing includes translocation testing, aneuploidy screening, and single gene testing. Natera offers constellation, a cloud-based software product that allows laboratory customers to gain access through the cloud to the company’s algorithms and bioinformatics in order to validate and launch tests. The company also undertakes clinical trial of several genetic materials. Natera is headquartered in San Carlos, California, the US.

Natera Inc (NTRA) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Natera Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
Natera Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 7
Natera Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
Natera Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 9
Natera Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 10
Natera Inc, Medical Equipment, Deal Details 12
Venture Financing 12
Natera Raises USD55.5 Million in Venture Financing 12
Natera Raises US$54.6 Million In Venture Financing 14
Gene Security Network Secures US$20 Million In Series D Financing 16
Partnerships 17
Unilabs Enters into Licensing Agreement with Natera 17
QIAGEN Enters into Agreement with Natera 18
Natera Enters into Agreement with Imperial College London and University of Leicester 19
Natera Enters into Research Agreement with Aarhus University 20
Natera Enters into Agreement with LifeLabs for Non-Invasive Prenatal Test 21
Diagcor Enters Into Agreement With Natera To Market Panorama NIPT In Hong Kong 22
Natera And Laboratorio Dr. F Echevarne Analisis Enter Into Agreement To Distribute Panorama 23
ARUP Labs Enters Into Co-Marketing Agreement With Natura For Panorama 24
Quest Diagnostics Enters Into Agreement With Natera To Offer Panorama, Non-Invasive Prenatal Screening Test 25
Equity Offering 26
Natera Prices Public Offering of Shares for USD90 Million 26
Natera Raises USD180 Million in IPO 28
Natera Inc – Key Competitors 30
Natera Inc – Key Employees 31
Natera Inc – Locations And Subsidiaries 32
Head Office 32
Other Locations & Subsidiaries 32
Recent Developments 33
Strategy And Business Planning 33
Jan 10, 2017: Natera terminates NIPT distribution agreement with Bioreference Labs 33
Financial Announcements 34
Aug 08, 2018: Natera reports second quarter 2018 financial results 34
May 08, 2018: Natera Reports First Quarter 2018 Financial Results 36
Mar 13, 2018: Natera Announces Fourth Quarter And Fiscal Year 2017 Financial Results 38
Nov 08, 2017: Natera Reports Third Quarter 2017 Financial Results 40
Aug 08, 2017: Natera Reports Second Quarter 2017 Financial Results 42
May 09, 2017: Natera Reports First Quarter 2017 Financial Results 44
Mar 07, 2017: Natera Reports Fourth Quarter and Fiscal Year 2016 Financial Results 46
Corporate Communications 48
Jul 31, 2018: Natera appoints Roy Baynes to Board of Directors adding deep oncology experience 48
Apr 09, 2018: Natera Appoints Paul R. Billings, M.D., Ph.D., as Chief Medical Officer 49
May 04, 2017: Natera Announces the Appointment of Gail Marcus as Member of the Board of Directors 50
Feb 03, 2017: Natera Announces Appointment of Mike Brophy as New Chief Financial Officer 51
Product News 52
Apr 13, 2018: Natera to Present Successful Results at AACR from Bladder and Colon Cancer Studies 52
Aug 21, 2017: Natera Launches Signatera Personalized Circulating Tumor DNA Technology for Cancer Research 53
Apr 26, 2017: Study in Nature Shows Early Relapse Detection in Lung Cancer Using Natera’s Technology for ctDNA Analysis 54
Other Significant Developments 55
Jun 19, 2018: Natera and Institut Jules Bordet partner on breast cancer research 55
Sep 20, 2017: Natera Selected for Circulating Tumor DNA Study in Bladder Cancer 56
Mar 01, 2017: Natera Announces Launch of Evercord Cord Blood and Tissue Banking Service 57
Appendix 58
Methodology 58
About GlobalData 58
Contact Us 58
Disclaimer 58

List of Tables
Natera Inc, Medical Equipment, Key Facts, 2017 2
Natera Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Natera Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
Natera Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 7
Natera Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
Natera Inc, Deals By Market, 2012 to YTD 2018 9
Natera Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 10
Natera Raises USD55.5 Million in Venture Financing 12
Natera Raises US$54.6 Million In Venture Financing 14
Gene Security Network Secures US$20 Million In Series D Financing 16
Unilabs Enters into Licensing Agreement with Natera 17
QIAGEN Enters into Agreement with Natera 18
Natera Enters into Agreement with Imperial College London and University of Leicester 19
Natera Enters into Research Agreement with Aarhus University 20
Natera Enters into Agreement with LifeLabs for Non-Invasive Prenatal Test 21
Diagcor Enters Into Agreement With Natera To Market Panorama NIPT In Hong Kong 22
Natera And Laboratorio Dr. F Echevarne Analisis Enter Into Agreement To Distribute Panorama 23
ARUP Labs Enters Into Co-Marketing Agreement With Natura For Panorama 24
Quest Diagnostics Enters Into Agreement With Natera To Offer Panorama, Non-Invasive Prenatal Screening Test 25
Natera Prices Public Offering of Shares for USD90 Million 26
Natera Raises USD180 Million in IPO 28
Natera Inc, Key Competitors 30
Natera Inc, Key Employees 31
Natera Inc, Subsidiaries 32

List of Figures
Natera Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Natera Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Natera Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Natera Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Natera Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
Natera Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 7
Natera Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
Natera Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 9

★海外企業調査レポート[Natera Inc (NTRA):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • SK Bioland Co Ltd:企業の戦略・SWOT・財務情報
    SK Bioland Co Ltd - Strategy, SWOT and Corporate Finance Report Summary SK Bioland Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Sterling Holiday Resorts (India) Limited:企業の戦略・SWOT・財務情報
    Sterling Holiday Resorts (India) Limited - Strategy, SWOT and Corporate Finance Report Summary Sterling Holiday Resorts (India) Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT …
  • Amarin Corp Plc (AMRN)-製薬・医療分野:企業M&A・提携分析
    Summary Amarin Corp Plc (Amarin) is a biopharmaceutical company which develops and commercializes medicines for cardiovascular domain. The company's lead product Vascepa (icosapent ethyl) is a US FDA approved single-molecule prescription capsule used as an adjunct to diet, for the reduction of trigl …
  • Toshiba Semiconductor Company:企業の戦略的SWOT分析
    Toshiba Semiconductor Company - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produ …
  • CEWE Stiftung & Co.KGaA (CWC):企業の財務・戦略的SWOT分析
    CEWE Stiftung & Co.KGaA (CWC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • BNC Bancorp:企業のM&A・事業提携・投資動向
    BNC Bancorp - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's BNC Bancorp Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, ca …
  • gategroup Holding AG:企業の戦略・SWOT・財務情報
    gategroup Holding AG - Strategy, SWOT and Corporate Finance Report Summary gategroup Holding AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • OraSure Technologies Inc (OSUR):医療機器:M&Aディール及び事業提携情報
    Summary OraSure Technologies Inc (OraSure) is a manufacturer and distributor of oral fluid specimen collection devices, diagnostic products and other medical devices. Its product portfolio encompasses infectious disease tests for the detection of antibodies for the HIV and Hepatitis C virus; Ebola v …
  • TOPS Markets, LLC:企業の戦略的SWOT分析
    TOPS Markets, LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …
  • Russian Aircraft Corporation MiG JSC:企業の戦略・SWOT・財務情報
    Russian Aircraft Corporation MiG JSC - Strategy, SWOT and Corporate Finance Report Summary Russian Aircraft Corporation MiG JSC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysi …
  • FDC Ltd (FDC):企業の財務・戦略的SWOT分析
    Summary FDC Ltd (FDC) is a pharmaceutical company that manufactures and markets of oral rehydration salts, ophthalmics and functional foods. The company also provides active pharmaceuticals ingredients (APIs). It provides products for the therapeutic segments of anti-infectives, gastrointestinals, o …
  • LCI Industries:企業の戦略・SWOT・財務分析
    LCI Industries - Strategy, SWOT and Corporate Finance Report Summary LCI Industries - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Power Mech Projects Ltd (POWERMECH):企業の財務・戦略的SWOT分析
    Power Mech Projects Ltd (POWERMECH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Community Health Systems Inc (CYH)-製薬・医療分野:企業M&A・提携分析
    Summary Community Health Systems Inc. (CHS) is an operator of general acute care hospitals and outpatient facilities in communities. The company’s services include general acute care services, emergency room services, general and specialty surgery, critical care, internal medicine, obstetrics and di …
  • Ascendance Biotechnology Inc-医療機器分野:企業M&A・提携分析
    Summary Ascendance Biotechnology Inc (Ascendance), formerly Hepregen Corp is a healthcare products provider that offers cell based assay products. The company provides vitro micro-liver cell-based platforms for use in safety testing, and pharmaceutical, biotherapeutic and diagnostic product developm …
  • Green Cross LabCell Corp (144510):製薬・医療:M&Aディール及び事業提携情報
    Summary Green Cross LabCell Corp (GCLabCell), a subsidiary of GC Pharma, is a biotechnology company that offers biopharmaceuticals. The company’s products include specialty medicines, blood products and vaccines, generic drugs, parenteral products, and genetically-modified hemophilia A drug Greenjun …
  • BC Technical Inc-医療機器分野:企業M&A・提携分析
    Summary BC Technical Inc (BC Technical), a subsidiary of MSouth Equity Partners is a medical device company that provides molecular imaging solutions. The company offers spare parts for new and refurbished nuclear medicine equipments for gamma cameras and BC backup server. It provides PET, PET/CT, N …
  • Bosideng International Holdings Limited:企業の戦略・SWOT・財務情報
    Bosideng International Holdings Limited - Strategy, SWOT and Corporate Finance Report Summary Bosideng International Holdings Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT a …
  • Integra LifeSciences Holdings Corp (IART):医療機器:M&Aディール及び事業提携情報
    Summary Integra LifeSciences Holdings Corp (Integra) is a medical technology company, which offers engineered collagen-based product lines. The company’s portfolio consists of surgical instruments, advanced wound care and orthopedic hardware, specialty metal implants, dermal regeneration products, o …
  • Attana AB-製薬・医療分野:企業M&A・提携分析
    Summary Attana AB (Attana) develops, manufactures and markets reagent kits and chip surfaces. The company offers products such as instruments, chip surfaces, reagents, kits and consumables; softwares, and accessories and spare parts. Its services comprise contract research, instrument training, atta …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆